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1. Introduction
The transition from epithelial to mesenchymal cells, 
as well as the reverse (mesenchymal-to-epithelial 
transition or MET), are highly dynamic processes 
implicated in various biological processes. EMT is well 
studied in the context of embryogenesis, organ fibrosis, 
and cancer metastasis, which highlight the categorical 
subtypes of EMT [1]. As our understanding of how 
EMT is regulated expands, it has become clear that 
EMT exists on a spectrum or continuum with various 
possible cell states existing between epithelial and 
mesenchymal phenotypes [2]. Cells do not necessarily 
exist in ‘pure’ epithelial or mesenchymal states, 
but instead can be in intermediate cell states (ICS) 
or hybrid states that possess characteristics of both 
epithelial and mesenchymal cells [2]. Context and 
tissue specific functions of EMT exist, but a number 
of key features and phenotypes are shared amongst the 
different subtypes of EMT [1, 2].
EMT involves the transient reduction and some-
times full loss of adhesion between epithelial cells. 
Hallmark changes include alterations in cytoskeleton 
architecture, changes in cell–cell and cell-matrix adhe-
sions, and loss of apical-basal polarities [3]. In the past, 
EMT identification had been focused on the expres-
sion of a few markers such as E-cadherin (E-cad); how-
ever, as our understanding of EMT has progressed, an 
expanded view of EMT identification encompasses 
multiple layers of molecular changes including EMT 
transcription factors (EMT-TFs) and their gene regu-
latory networks that govern the transition [2]. A num-
ber of key EMT-TFs such as Snail1/Slug and Zeb1/2 
have been identified in promoting the mesenchy-
mal phenotype while other TFs such as Ovol1/2 and 
Grhl2 have been shown to suppress the mesenchymal 
phenotype thus promoting the epithelial phenotype 
[2, 3]. EMT regulation also occurs at the microRNA, 
long noncoding RNA, chromatin, and post-transla-
tional levels [2].
2. EMT in normal and diseased epithelial 
tissues
The development and maintenance of epithelial 
tissues is largely driven by epithelial stem cells [4]. 
The dynamic activities of these stem cells such as 
proliferation and differentiation vary depending on 
the stage of the tissue such as during development, 
adult regeneration, or in pathological conditions such 
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Abstract
The transition of epithelial cells into a mesenchymal state (epithelial-to-mesenchymal transition or 
EMT) is a highly dynamic process implicated in various biological processes. During EMT, cells do 
not necessarily exist in ‘pure’ epithelial or mesenchymal states. There are cells with mixed (or hybrid) 
features of the two, which are termed as the intermediate cell states (ICSs). While the exact functions 
of ICS remain elusive, together with EMT it appears to play important roles in embryogenesis, tissue 
development, and pathological processes such as cancer metastasis. Recent single cell experiments 
and advanced mathematical modeling have improved our capability in identifying ICS and provided 
a better understanding of ICS in development and disease. Here, we review the recent findings 
related to the ICS in/or EMT and highlight the challenges in the identification and functional 
characterization of ICS.
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as cancer [4]. Increasing evidence implicates EMT 
(and its regulation) as being another cellular dynamic 
component that can promote stem cell function [2]. 
In general, stem cell function in adult epithelial tissues 
is largely focused on the homeostatic maintenance 
of the tissue where cells that are differentiated or lost 
need to be replaced [4]. In line with the notion that 
EMT exists in a spectrum of states and degrees, its 
role can vary depending on the epithelial tissue, stage 
of development, whether the tissue is undergoing 
regeneration or repair, and the pathological condition 
[2]. Below we highlight several instances of EMT 
function and regulation in committed epithelial tissues 
in different contexts such as normal development, 
adult regeneration and repair, and briefly discuss in 
the context of cancer (readers are referred to other 
comprehensive reviews on this topic, e.g. [2]).
The normal and cancerous mammary epithelium 
has been utilized as a model to study the potential role 
and regulation of EMT in epithelial stem cell func-
tion. Experiments using immortalized human mam-
mary epithelial cells provided in vitro evidence that 
ectopic expression of EMT-TFs Snail1 and Twist leads 
to acquisition of stem-like activities [5]. A positive 
correlation between heightened EMT gene signature 
and stem cell fate has also been noted for normal and 
cancerous mammary epithelial cell types in culture 
or directly isolated from the human or mouse tissue 
[6, 7]. These data generated much interest in EMT as 
they suggest a link between EMT and the gain of stem-
like features.
Further work in the mammary model in vivo found 
that Snai2 (Slug) is the major EMT-TF expressed in 
mouse mammary basal cells known to contain multi-
potent stem cells, and that ectopic expression of Snai2 
leads to enhanced stem-like features [8]. Moreo-
ver, knockout or knockdown of Snai2 compromises 
mammary epithelial development and/or the ability 
of primary mammary epithelial cells to regenerate a 
mammary tree [8, 9]. Zeb1 has also been found to be 
expressed in normal mouse and human mammary 
basal cells [10], with expression particularly enriched 
in the Procr+ stem cell subset [7]. However, its func-
tional significance remains to be elucidated. Interest-
ingly, using a transgenic mammary tumor model, 
Snail1- but not Snai2- expressing cells appeared in the 
early hyperplastic lesions as well as more high-grade 
carcinomas [11]. These cells lack E-cad expression and 
begin to express other EMT-TFs such as Zeb1, suggest-
ing that Snail1 (but not Snai2) is responsible for gov-
erning the EMT program in cancer progression [11]. 
These observations highlight the notion that different 
EMT-TFs can have different, context-specific func-
tions even in the same tissue, and the exact underlying 
molecular and cellular mechanisms may differ. Thus, 
we emphasize again the importance to now expand 
our view of EMT beyond a simple binary, linear or uni-
versally identical process with the end goal of gener-
ating mesenchymal cells. EMT can be thought of as a 
historical term that is redirected to describe the diverse 
and complex variant forms associated with epithelial-
mesenchymal plasticity. Specifically, EMT may be con-
sidered a navigation through a rugged, highly nonlin-
ear multidimensional landscape of different axes that 
cumulatively define EMT [12, 13]. On this landscape, 
cell states other than epithelial and mesenchymal cells 
often exist, exhibiting mixed (or hybrid) features of 
epithelial and mesenchymal states. Such cell states, 
termed as intermediate cell states (ICSs) in this paper, 
may play important roles in regulating transitions 
between epithelial cells and mesenchymal cells.
Growing evidence also points to the importance of 
regulating EMT during physiological epithelial devel-
opment and regeneration. Within the mammary epi-
thelium, suppression of EMT by Elf5 and Ovol2 TFs 
appears to be an integral component of its normal 
development and regeneration [14, 15]. Loss of Ovol2 
in the mammary epithelium results in an up-regula-
tion of a large number of EMT/mesenchymal markers 
such as vimentin (Vim) and EMT-TFs such as Zeb1, 
as well as in vivo morphological transformation remi-
niscent of EMT [15]. Importantly, many of these EMT 
genes are direct targets of Ovol2’s transcriptional 
repressor activity and depletion of Zeb1 rescues the 
regenerative defect caused by Ovol2 deficiency [15], 
underscoring an EMT-centric function of Ovol2 in the 
mammary gland. Interestingly and adding to the clini-
cal importance of EMT regulation, incidence of metas-
tasis-free survival increases in breast cancer patients 
with high levels of Ovol2 [15].
Transcriptional inhibition of EMT by Ovol2 and 
its homolog, Ovol1, is also critically important for 
normal skin epithelial development during embryo-
genesis. Loss of both Ovol2 and Ovol1 leads to defec-
tive epidermal and hair follicle morphogenesis [16]. 
Similar to the observations in the mammary gland, 
loss of Ovol leads to up-regulated expression of EMT 
structural markers and EMT-TFs, as well as EMT-like 
phenotypes such as reduced adhesion between, and 
aberrant migration of, embryonic epidermal cells [16]. 
In adult skin, loss of Ovol2 alone results in defective 
wound healing [17], a process that has been proposed 
to involve partial EMT of wound peripheral epidermal 
cells so they can efficiently migrate to close the wound 
[2, 18, 19]. Ovol2-deficient epidermal and hair follicle 
stem cells migrate faster than their normal counter-
parts, but with significantly reduced directionality 
[17]—defects that are near-completely rescued when 
EMT-TF Zeb1 is simultaneously lost. On the other 
hand, loss of EMT-TF Snai2 compromises epidermal 
migration after wounding, and results in a thin epider-
mis and transient delay of hair growth during normal 
development [19–21]. Together these data suggest that 
a delicate balance of EMT regulation exists to maintain 
both epithelial-like and mesenchymal-like states and 
this ability to toggle between the two states might be 
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critical for skin epithelial development and regenera-
tion.
The study of EMT in cancer has largely been 
focused on its role in promoting invasion and 
metastasis with an involvement in chemoresistance 
recently demonstrated [2]; however many questions 
remain unanswered. Conflicting literature exists and 
the extent of EMT importance in patients’ clinical 
outcomes remains unclear [2]. The roles of partial 
EMT and intermediate states in the context of cancer 
is still not well understood likely due to the transient 
nature of these events [2, 22]. The variation of different 
EMT-TFs’ expression together with the diverse cell 
types in the tissues of origin adds to the complexity. 
Below we delve deeper into the idea of intermediate 
states and discuss relevant existing data in the contexts 
of both normal and diseased cells.
3. Existence of ICS in EMT
During EMT, cells exist on a reversible spectrum, and 
can toggle between ICSs, which lie between epithelial 
and mesenchymal states. Several lines of evidence 
using in vitro, in vivo, and computational modeling 
suggest the existence of ICS.
In vitro models that have focused on using 
various cell lines are largely focused on the dual 
expression of epithelial and mesenchymal markers for 
identification of ICS. Glomerular parietal epithelial 
cells (GPECs) from adult mouse kidney adopt an 
intermediate phenotype expressing both epithelial and 
mesenchymal markers [23]. The MCF10A mammary 
epithelial cell line exists in an ICS with expression of 
both epithelial (E-cad) and mesenchymal (VIM) 
markers as compared to other well characterized 
breast cancer cell lines [24]. Cancerous cell lines have 
also been shown to exhibit ICS. Some cells from the 
human non-small-cell lung cancer cell line A549 
are in an intermediate EMT state in culture based on 
co-expression of VIM and SNAI2 [25]. ITGB4+ triple-
negative breast cancer stem cell-enriched cells reside 
in an intermediate state between ‘pure’ epithelial 
and mesenchymal cells [26]. Research from a number 
of groups indicates that individual carcinoma cells, 
rather than all cells at a population level, can exist in 
ICSs. Distinguished by the widely used cell-surface 
markers resolving epithelial and mesenchymal cells, 
single CD24+/CD44+ cells in tumorigenic human 
mammary epithelial cells are ICS cells [27]. H1975 lung 
cancer cells co-stained for both VIM and E-cad display 
an ICS phenotype at a single-cell level [28]. Circulating 
tumor cells from human breast cancer cell lines 
captured by a microfluidic device from blood exhibit 
both epithelial (MCF7 and SKBR3) and mesenchymal 
(MDA-MB-231) characteristics, indicating existence 
of potential ICSs [29]. The classical view of the 
metastatic cascade depicts a sequence of events 
including dissemination, invasion, intravasation, and 
eventually extravasation, and ICS cells expressing both 
epithelial and mesenchymal features can be observed 
at these different stages; however, dissecting the exact 
role that EMT plays at these stages in vivo has proven to 
be difficult [2].
Findings generated by modeling and 
computational approaches also support the idea 
of ICS. Modeling of the microRNA (miR)-based 
chimeric modules showed the miR-200/Zeb 
module functions as a ternary switch, allowing an 
intermediate phenotype in addition to the epithelial 
and mesenchymal phenotypes [30]. Random circuit 
perturbation (RACIPE), interrogating the robust 
dynamical behavior of a gene regulatory network, 
has identified two different types of intermediate 
phenotypes when applying to a proposed 22-gene 
network of EMT [31]. A topographic map using the 
combination of numerical simulations of a Boolean 
network model and the analysis of bulk and single-cell 
gene expression data revealed multiple ICSs, separating 
stable epithelial and mesenchymal states [32]. Energy-
landscape based methods like scEpath could also be 
used to identify ICS [33] and the landscape of the free 
energy changes during the EMT of lung cancer cells 
suggests a stable ICS [34].
Previous studies predicted that multiple ICSs may 
exist between epithelial and mesenchymal states [35], 
but the number of intermediate phenotypes is still a 
matter of debate [36]. Recent experiments have pro-
vided evidence for one, two and three intermediate 
phenotypes from TGF-β–induced EMT in MCF10A 
cells [37], ovarian carcinoma (OC) cell lines [38], and 
circulating tumor cells in blood [29], respectively. 
While theoretical analysis helps to predict the number 
of ICSs, modeling studies have revealed that complex 
EMT regulatory networks govern the existence of mul-
tiple ICSs [39]. Modeling of miRNA-based regulation 
composed of a tristable circuit miR-200/Zeb driven by 
the monostable module miR-34/Snail1 allowed one 
intermediate EMT phenotype [30]. Ovol can modu-
late cellular plasticity by restricting EMT, driving MET, 
expanding the existence of the ICS and turning both 
EMT and MET into two-step processes based on the 
mechanism-based mathematical model coupling 
Ovol with the core regulatory network miR-200/Zeb 
[40]. Later, two distinct intermediate phenotypes in 
EMT dynamics were predicted and experimentally 
validated, and were shown to be modulated by Ovol2 
and the Ovol2-Zeb1 mutual inhibition circuit [24]. 
Recently, analysis of a mathematical model that inte-
grates expression data with the reported Tcf21-Slug 
interactions reveals one stable and two metastable 
ICSs in EMT [41].
4. Roles of ICS
4.1. Stemness
Recent theoretical and experimental studies have 
suggested that cells in ICSs can be more stem-like 
than both ‘pure’ epithelial and mesenchymal cells. 
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For example, trophoblast stem cells isolated from the 
conceptuses of MAP3K4 kinase-inactive mouse (TSKI4) 
cells are found to be trapped in an ICS and exhibit 
properties of both EMT and stemness [42]. Other cells 
at ICS states may also acquire stemness. For example, co-
culture of cells from E and M states actually enhances 
mammosphere formation (an assay for stemness), 
and the isolation of the CD24+/CD44+ hybrid E/M 
cell state leads to enhanced stemness [27]. In another 
example, more than 90% of CD24+ cells from kidney 
GPECs show co-expression of surface markers of renal 
progenitors CD24 and cadherin-11, suggesting that 
these cells have acquired stem cell-like properties [23].
Mathematical modeling and computational analy-
sis also predict that the ICS confers stemness poten-
tial. A model on three-way switch LIN28/let-7 circuit 
and a model on EMT-STEM-Notch coupled circuit 
both revealed a high likelihood of an ICS phenotype 
(when compared with either epithelial or mesenchy-
mal states) in gaining stemness [43, 44]. Moreover, the 
ICS location in the low-dimensional gene expression 
space can shift towards either end of the EMT spec-
trum, and a crosstalk between EMT and stem cell regu-
latory modules in conjunction with Notch signaling 
creates a window of opportunity for stemness [44]. If 
one could reduce the size of the window or shift the 
window away from the mesenchymal end of the EMT 
space, the tumor would be less aggressive in growth or 
invasiveness [45].
ICS importance has also been analyzed in other 
systems not directly related to EMT [39]. For example, 
based on a five-node stochastic gene regulatory 
network controlling cellular stemness, ICS is found to 
significantly decrease the barrier of potential landscape 
and the minimal action value along the transition path 
to promote the differentiation process [46]. Clearly, 
additional experimental studies are needed to clarify 
the mechanistic link between ICS and stemness, the 
relationship of which may be correlative rather than 
casual in some cases.
4.2. Collective migration
The ability of cells in ICS to migrate in a collective 
manner has been implicated during embryonic 
development, wound healing and the formation of 
tumor cell clusters [19, 28, 47, 48]. Cells undergoing 
collective migration display some migratory 
characteristics reminiscent of mesenchymal cells 
while maintain epithelial characteristics, implicating 
a connection to the ICS. For example, collective 
migration of H1975 lung cancer cells in vitro is 
associated with an ICS phenotype, and both are 
impaired after depletion of EMT-inhibiting TFs [28]. 
Cross-talks between Tcf21 and Slug have been identified 
to mediate phenotypic and migration plasticity in 
high-grade serous ovarian adenocarcinoma, and ICSs 
were found to be important in collective cell migration 
[41]. As discussed above, our recent studies highlight 
the importance of balancing the functions of EMT-
inhibiting TF Ovol2 and EMT-TF Zeb1 in achieving 
directional cell migration of skin epithelial cells to 
support tissue repair and regeneration [17].
4.3. Drug resistance
The ICSs in EMT have great clinical relevance as they 
have been associated with drug resistance. The triple-
negative breast cancer cells, which contain a number 
of intermediate E/M cells in primary tumor [29], 
exhibit de novo resistance to current standard therapies 
such as anthracyclines and taxanes [49, 50]. However, 
the underlying signaling pathways and molecular 
mechanisms of the interplay between ICS and drug 
resistance remain largely elusive [50].
4.4. Metastasis
The overarching role of EMT in metastasis has been 
extensively studied, however the precise role of ICS 
remains unclear. During the metastatic cascade, cells in 
primary tumor adopt mesenchymal-like features and 
are then able to leave the primary tumor and colonize in 
other locations, such as in mouse breast or pancreatic 
cancer models where Snail1-positive or ‘EMTing’ cells 
are sometimes fully detached from epithelial islands 
while losing E-cad expression [51]. The EMT-TF 
Zeb1 has been shown to be important for promoting 
a spectra of tumor types from mesenchymal, mixed 
(possibly at ICS), and epithelial as its loss leads to a 
confined epithelial state in pancreatic cancer [52]. In 
vivo live cell imaging coupled with gene expression 
analysis indicates that cells disseminated from 
primary tumors exhibit low expression of E-cad and 
enhanced expression of mesenchymal markers [53], 
suggesting that those cells have characteristics of ICSs. 
Interestingly, in a pancreatic cancer model, deletion 
of Twist or Snail1 does not cause any alterations in 
invasiveness [54], indicating cells (possibly ICS) that 
lose some of the well-studied mesenchymal markers 
may possess mesenchymal-like features. Along the 
same lines, in a lung metastases model, although EMT 
occurs within the primary epithelial tumor, the initial 
lung metastases are mainly derived from non-EMT 
tumor cells [55], and EMT cells do play a major role 
in recurrent lung metastasis after chemotherapy [55]. 
Beyond the gain of mesenchymal-like features during 
primary tumor dissemination, dynamic EMT gene 
expression is also observed in circulating breast tumor 
cells [29]. Together these data suggest that during EMT 
there are cells other than mesenchymal cells showing 
mesenchymal-like features with tissue and context 
specific roles during metastasis. Further analysis on 
such cells and their connection with ICS is important 
for better understanding of metastasis.
4.5. Speculated roles of ICS: controlling noise and 
dynamical robustness
Mathematical modeling and computational analysis 
have shown that ICS has the ability to control noise and 
increase the robustness of EMT dynamics. Increased 
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number of intermediate phenotypes in the EMT system 
can better attenuate the overall fluctuations of the cell 
population in terms of phenotypic compositions, 
thereby stabilizing a heterogeneous cell population 
on the EMT spectrum, via a dynamic ODE modeling 
of the population of each cell phenotype [56]. The 
existence of ICS can also allow noise attenuation while 
maintaining the mean of the signal [57]. In another 
example using a regulatory circuit of miR-200, Zeb, 
and Snail1, the ICS is observed to increase the plasticity 
of cell fate and the robustness of EMT dynamics 
[58]. With ICS, the EMT process can be carried out 
through transition first from the epithelial state to a 
ICS temporarily, and making further transition then 
from the ICS to the mesenchymal state or directly 
going from the epithelial state to the mesenchymal 
state. Moreover, cells at ICS can go back to epithelial 
state at other times, depending on the signal inputs for 
flexibility [58].
4.6. Stability
The ICS of EMT has been considered ‘metastable’  
[35, 59], reflecting the flexibility of these cells 
to undergo or reverse the EMT process [60]. In 
angiogenesis, hybrid tip/stalk phenotype, resulting 
from higher production levels of Jagged, relates with 
poorly perfused and chaotic angiogenesis based on 
the theoretical framework for Notch-Delta-Jagged-
VEGF signaling [61]. But some evidence show that ICS 
could be stable. Experimentally, H1975 lung cancer 
cells can display a stable ICS over 2 months in culture 
[28]. In addition, the landscape of the free energy 
changes during EMT of the lung cancer cells shows a 
stable intermediate state [34]. Not only in EMT, ICS of 
immune system’s T-helper cells are also observed and 
are stable, having two canonical subtypes [62].
Interestingly, computational modeling that con-
siders the mutual inhibitory loops between several 
miRNAs and EMT-TFs indicates that such networks 
are capable of generating additional stable ICSs 
[2, 24, 28] and have identified multiple phenotypic sta-
bility factors, such as Ovol, GRHL2, miR-145 [28] and 
NUMB, that can stabilize an intermediate E/M pheno-
type [63]. What’s more, ICSs can be stabilized due to 
the increase of gene expression noises [31, 64].
5. Rising issues and challenges
Recently, single-cell RNA sequencing (scRNA-
Seq) has emerged as a powerful means to dissect the 
heterogeneity in normal and diseased epithelial tissues. 
The ability to sample the transcriptome and quantify 
gene expression changes at single-cell resolution has 
yielded unprecedented insights into the physiology 
of epithelial systems by aiding in the discovery of rare 
cell types, shedding light on the dynamics of lineage 
differentiation, and providing comprehensive gene 
expression profiles of diverse cell types [10, 65]. scRNA-
Seq has also begun to be employed to better understand 
the transition states that occur during EMT in cancer. 
In a recent study, scRNA-Seq revealed the presence 
of a partial EMT-like state in human squamous cell 
carcinoma (SCC) samples, implicating the existence 
of ICS in vivo. Another study utilized mouse models 
of SCC and mammary tumorigenesis for single-cell 
surface marker/RNA-seq analyses, and identified 
subpopulations of tumor cells corresponding to 
different degrees of EMT, with some displaying hybrid 
phenotypes that likely represent multiple distinct ICSs 
in vivo [66]. It is anticipated that single-cell approaches 
will also reveal EMT-related heterogeneity and enable 
the detection of ICSs in various normal epithelial 
tissues. Indeed, sequencing of 1916 single cells from 
eight different organs from E9.5 to E11.5 embryos led 
to the identification of epithelial-mesenchymal ICSs in 
all epithelial tissues sampled, including intestine, liver, 
lung, and skin [67].
In addition to characterizing ICSs, single-cell 
approaches have been used to suggest a role for 
EMT and/or ICS in development/differentiation 
and disease. Using an experimental pipeline that 
incorporates single-cell qPCR analysis, it was shown 
that human embryonic stem cells (hESCs) go through 
a stepwise differentiation process into hepatocytes by 
undergoing sequential EMT-MET with an obligatory 
ICS, implicating a potential role for EMT/ICS in 
hESC differentiation into a definitive endodermal 
fate [68]. The SCC cells of the distinct ICSs discussed 
above display different clonogenic and differentiation 
potentials, as well as distinct invasive and plastic 
properties, providing experimental evidence that 
the different transition states that arise from EMT 
progression have different biological functions [66].
It has become increasingly clear that ICSs during 
EMT are important biological entities and must be 
considered whenever EMT is studied. The exact roles 
of EMT, and particularly of the constituent ICSs in 
different developmental and disease contexts need to 
be investigated using a combination of experimental 
and computational approaches. It would be interesting 
to computationally model the overall dynamics of the 
cellular states in a continuum fashion to capture their 
relatively unstable properties rather than studying 
multiple statuses in between the main stable states. 
Developing sophisticated computational tools that 
facilitate the identification and characterization of 
various ICSs—cell states that are more transient 
and may be different from other major cell states—
represents a major challenge as well as opportunity in 
the EMT field.
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